A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain …
P Honore, CT Wismer, J Mikusa, CZ Zhu… - … of Pharmacology and …, 2005 - ASPET
The vanilloid receptor 1 (VR1, TRPV1), which is a member of the transient receptor potential
(TRP) superfamily, is highly localized on peripheral and central processes of nociceptive …
(TRP) superfamily, is highly localized on peripheral and central processes of nociceptive …
A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain …
P Honore, CT Wismer, J Mikusa… - The Journal of …, 2005 - pubmed.ncbi.nlm.nih.gov
The vanilloid receptor 1 (VR1, TRPV1), which is a member of the transient receptor potential
(TRP) superfamily, is highly localized on peripheral and central processes of nociceptive …
(TRP) superfamily, is highly localized on peripheral and central processes of nociceptive …
A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain …
R El Kouhen, CR Faltynek, DM Gauvin… - … of Pharmacology and …, 2005 - hero.epa.gov
Abstract The vanilloid receptor 1 (VR1, TRPV1), which is a member of the transient receptor
potential (TRP) superfamily, is highly localized on peripheral and central processes of …
potential (TRP) superfamily, is highly localized on peripheral and central processes of …
A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain …
P Honore, CT Wismer, J Mikusa, CZ Zhu… - The Journal of …, 2005 - europepmc.org
The vanilloid receptor 1 (VR1, TRPV1), which is a member of the transient receptor potential
(TRP) superfamily, is highly localized on peripheral and central processes of nociceptive …
(TRP) superfamily, is highly localized on peripheral and central processes of nociceptive …
[引用][C] A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological …
P HONORE - J Pharmacol Exp Ther, 2005 - cir.nii.ac.jp
A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor
potential type V1 receptor antagonist, relieves pathophysiological pain associated with …
potential type V1 receptor antagonist, relieves pathophysiological pain associated with …
[引用][C] A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological …
P HONORE - J Pharmacol Exp Ther, 2005 - cir.nii.ac.jp
A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor
potential type V1 receptor antagonist, relieves pathophysiological pain associated with …
potential type V1 receptor antagonist, relieves pathophysiological pain associated with …